A TREATMENT IND (INVESTIGATIONAL NEW DRUG) PROTOCOL FOR THE USE OF VIDEX (2',3'-DIDEOXYINOSINE, DDI) IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) OR AIDS- RELATED COMPLEX (ARC) WHO ARE INTOLERANT TO ZIDOVUDINE (RETROVIR):